Patent Assignment
Reel/Frame 029799/0958
Change of Name
Recorded: 2013-02-12
Pages: 7
Assignor
TALIGEN THERAPEUTICS, INC.
Executed: 2011-01-28
Assignee
ALEXION CAMBRIDGE CORPORATION
245 FIRST STREET, SUITE 1100, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Humaneered Anti-Factor B Antibody
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 12, 2013
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 029799/0771 →
Change of Address
Feb 12, 2013
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029801/0586 →
Merger
Jun 19, 2015
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 035866/0477 →